Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Juan Carlos Ivancevich, MD"'
Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients
Autor:
Désirée Larenas-Linnemann, MD, Blanca María Morfin-Maciel, MD, Martín Bedolla-Barajas, MD, MSc, Ana López-Bago, MD, Elsy Maureen Navarrete Rodríguez, MD, MSc, María Dolores Mogica-Martínez, MD, José E. Gereda, MD, Mauricio Sarrazola Sanjuan, MD, MSc, Rosa Yazmín Cano Pedroza, MD, María Cecilia Cavallo, MD, Sergio de Jesús Romero Tapia, MD, Roberto A. Jossen, MD, José Miguel Fuentes Pérez, MD, Blanca E. Del Rio Navarro, MD, Erendira Rodríguez Zagal, MD, Pedro A. Piraino Sosa, MD, Yunuen Rocío Huerta Villalobos, MD, Pierre Chavez-Vereau, MD, Daniel Alberto García Imperial, MD, Margarita Olivares Gómez, MD, Francisco Valle Rodríguez, MD, Carlos Omar Zuñiga Reyes, MD, Mónica Rodríguez-González, MD, Claudia Ivonne Gallego Corella, MD, Juan Carlos Ivancevich, MD, María de la Luz Hortencia García Cruz, MD, María Susana Repka-Ramirez, MD, Mauricio Ernesto Flores Morales, MD, Juan Carlos Fernández De Córdova Aguirre, MD, MSc, Jorge A. Luna-Pech, MD, PhD, Daniela Rivero Yeverino, MD, Edgar Martínez Guzmán, MD, Cinthia Elizabeth Pérez Ortiz, MD, Leonor Villa Médica, MD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 5, Pp 100779- (2023)
Introduction: Allergen immunotherapy (AIT) brings along changes in the immune system, restoring dendritic cell function, reducing T2 inflammation and augmenting the regulatory cell activation. Coronavirus disease (COVID-19), caused by severe acute re
Externí odkaz:
https://doaj.org/article/cd7960e0d97546b88f333cb19e028f58
Autor:
Emilio Alvarez-Cuesta, MD, PhD, MQM, Ricardo Madrigal-Burgaleta, LMS, MD, PhD, Ana D. Broyles, MD, Javier Cuesta-Herranz, MD, PhD, Maria Antonieta Guzman-Melendez, MD, PhD, Michelle C. Maciag, MD, Elizabeth J. Phillips, MD, Jason A. Trubiano, MBBS, PhD, Johnson T. Wong, MD, Ignacio Ansotegui, MD, PhD, F. Runa Ali, MBBS, PhD, FRCP, Denisse Angel-Pereira, MD, Aleena Banerji, MD, Maria Pilar Berges-Gimeno, MD, PhD, Lorena Bernal-Rubio, MD, Knut Brockow, MD, Ricardo Cardona Villa, MD, Mariana C. Castells, MD, PhD, Jean-Christoph Caubet, MD, Yoon-Seok Chang, MD, PhD, Luis Felipe Ensina, MD, MSc, PhD, Manana Chikhladze, PhD, Anca Mirela Chiriac, MD, PhD, Weng-Hung Chung, MD, PhD, Motohiro Ebisawa, MD, PhD, Bryan Fernandes, MBBS, MRCP, Lene Heise Garvey, MD, PhD, Maximiliano Gomez, MD, PhD, Javier Gomez Vera, MD, Sandra Gonzalez Diaz, MD, PhD, David I. Hong, MD, Juan Carlos Ivancevich, MD, Hye-Ryun Kang, MD, PhD, David A. Khan, MD, Merin Kuruvilla, MD, Jose Ignacio Larco Sousa, MD, Patricia Latour-Staffeld, MD, Anne Y. Liu, MD, Eric Macy, MD, Hans Jorgen Malling, MD, Jorge Maspero, MD, Sara M. May, MD, Cristobalina Mayorga, PhD, Miguel A. Park, MD, Jonathan Peter, MBChB, PhD, Matthieu Picard, MD, FRCPC, Tito Rodriguez-Bouza, MD, PhD, Antonino Romano, MD, Mario Sanchez-Borges, MD, Luciana Kase Tanno, MD, PhD, Maria Jose Torres, MD, PhD, Alicia Ureña-Tavera, MD, Rocco L. Valluzzi, MD, Gerald W. Volcheck, MD, Masao Yamaguchi, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 6, Pp 100640- (2022)
Drug hypersensitivity reactions (DHRs) to intravenous drugs can be severe and might leave patients and doctors in a difficult position where an essential treatment or intervention has to be suspended. Even if virtually any intravenous medication can
Externí odkaz:
https://doaj.org/article/e0c0af27bfeb4f85870d85af3c354589